PRESS RELEASES
ALWAYS STAY IN THE KNOW!
Subscribe now to our mailing list to receive the latest press releases.
Sep 29, 2025
iFabric & Doctor’s Choice® Sign Next-Generation Scrubs & Medical Apparel Agreement
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA OTCQX: IFABF) today announced that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. (“IFTNA”), has signed a license agreement with Mercury Athletics LLC, owner of the Doctor’s Choice® brand, to design, manufacture, and market scrubs and medical apparel under the Doctor’s Choice brand name. The program will incorporate multiple IFTNA textile technologies, led by PROTX2®, across relevant healthcare end-user categories and sales channels.
Sep 22, 2025
iFabric Announces Renewal of License Agreement with TUMI to Continue Integration of
PROTX2® Technology
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA OTCQX: IFABF) today announced that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. (“IFTNA”), has renewed its license agreement with TUMI, Inc. (“TUMI”) to continue integrating IFTNA’s PROTX2® antimicrobial solutions across select TUMI products. The renewal extends the relationship first announced on May 5, 2021, by a further period of five years.
Sep 3, 2025
iFabric Corp. Announces Expansion of PROTX2 Technology into the UK and EU; Marks
& Spencer to Adopt for Autograph Collections
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA,
OTCQX: IFABF), a leader in innovative fabric and performance-apparel technologies, today announced that its Intelligent Fabric Technologies Division has expanded deployment of its advanced PROTX2 technology into the United Kingdom and European Union. British retail icon Marks & Spencer will be adopting PROTX2 for select items within its Autograph collections. The PROTX2 brand mark will now appear on both in-store and online merchandise hang tags to signal its unique performance benefits to consumers.
Aug 19, 2025
iFABRIC ANNOUNCES PUBLICATION OF GROUNDBREAKING CLINICAL TRIAL PROVING THE INFECTION
CONTROL ABILITY OF PROTX2® AND ecoPEL™ TREATED SCRUBS
iFabric Corp. (TSX: IFA, OTCQX: IFABF), is pleased to announce that the results of its clinical trial, “Antimicrobial-treated fabric scrubs can prevent pathogen proliferation
on scrubs”, has been officially published in the Journal of Hospital Infection, the editorially independent scientific publication of the Healthcare Infection Society. The aim of the Journal is to publish high quality research and information relating to infection prevention and control that is relevant to an international audience.
Mar 31, 2025
IFABRIC CORP REPORTS RECORD Q4 AND FULL YEAR 2024 REVENUES AND STRONG PROFITABILITY
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA, OTCQX: IFABF), today announced its audited results for its fourth quarter and fiscal year ended December 31, 2024 (“2024”), with record revenues and strong profitability.
Feb 3, 2025
iFabric Corp. Announces Fifth Consecutive Year of Revenue Growth
iFabric Corp. (TSX: IFA, OTCQX: IFABF), a leading provider of innovative functional-fabrics, value added specialty apparel, and surface-treatment technologies, is pleased to announce its fifth consecutive year of revenue growth, with the last two years each reflecting strong, double-digit increases.
Aug 14, 2024
iFabric Corp. Reports Record Revenues and Strong Performance for Q2 2024.
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA, OTCQX: IFABF), today announced its financial results for the second quarter ended June 30, 2024. The Company reported record revenues and notable increases in gross profit and adjusted EBITDA, reflecting continued strong performance.
Apr 30, 2024
iFabric Corp. Receives FDA Medical Device Registration for Apparel Products Utilizing Multiple Textile Technologies
iFabric Corp. (“iFabric” or the “Company”) (IFA.TO, OTCQX: IFABF), a leading provider of innovative apparel and textile technologies, announces its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. (“IFTNA”), has successfully obtained a U.S. Food and Drug Administration (“FDA”) Medical Device Registration for its revolutionary apparel products integrating multiple textile technologies.
Apr 23, 2024
iFabric Corp. Announces US EPA Registration of TWO New Cutting-Edge Antimicrobial Technologies
iFabric Corp. (“iFabric” or the “Company”) (IFA.TO, OTCQX: IFABF), a leading provider of innovative apparel and textile technologies, announces that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. (“IFTNA”), has received United States Environmental Agency (“EPA”) registrations for two of its latest antimicrobial textile innovations. This significant milestone underscores iFabric’s commitment to providing groundbreaking solutions to meet the evolving needs of our customers and addressing emerging challenges in the field of antimicrobial protection.
Apr 2, 2024
IFABRIC CORP REPORTS INCREASED REVENUES FOR ITS FINANCIAL PERIOD ENDED DECEMBER 31, 2023.
April 2, 2024, iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA, OTCQX: IFABF), today
announced its results for its fifth quarter and fiscal period ended December 31, 2023 (“2023”). With effect
from October 1, 2022, the Company changed its financial year end to December 31. Accordingly, the financial
statements for 2023 are presented for a period of fifteen months compared to twelve months in 2022.
Nov 8, 2023
IFABRIC CORP ANNOUNCES EXPANSION MOVE
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA, OTCQX: IFABF), today announced that it has executed a lease agreement for the rental of approximately 5,000 square feet of office space in Markham, Ontario, at a commercial office building near its current head office and warehouse location. The new offices will house the Canadian management and administrative personnel of the Company. After the move, the current Company owned building located at 525 Denison Street, Markham, Ontario, which currently comprises a mix of warehouse and office space, will be fully repurposed as warehouse space.
Oct 23, 2023
IFABRIC CORP. ANNOUNCES MAIDENFORM® LICENSE RENEWAL
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA, OTCQX: IFABF), today announced that its wholly owned subsidiary company, Coconut Grove Pads Inc. ("CGP"), has renewed its license and distribution agreement with HBI IP Holdings Switzerland GmbH (“HBI”) and Maidenform LLC (“Maidenform”), both subsidiaries of HanesBrands Inc. (“HanesBrands”). The agreement covers the distribution by CGP of intimate apparel accessories and specialty bra solutions which are marketed under HanesBrands’ Maidenform® brand.
May 15, 2023
iFabric Corp Reports a Record 91% Increase in Second Quarter Revenues
iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF), today announced record financial results for its second quarter and six months ended March 31, 2023, an outcome directly related to the Company's commitment to accelerating revenue growth through product design innovation, technology integration and new customer acquisitions.
May 2, 2023
iFabric Corp. Announces Breakthrough in EPA Public Health Claims Approval Process with Initial Registration of PROTX2 for Use in Non-Apparel Products
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA, OTCQX: IFABF), today announced that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has received a United States Environmental Agency ("EPA") registration for PROTX2® as a “Continually Self-Sanitizing Textile”. This registration allows textiles treated with the PROTX2 technology, to make public health claims for use in non-apparel products, which includes, curtains, carpeting and home furnishing fabrics, amongst others.
Mar 9, 2023
IFABRIC ANNOUNCES EXTENSION OF PERIOD TO EXERCISE WARRANTS
IFABRIC CORP. (“iFabric” or the "Company") (TSX: IFA, OTCQX: IFABF) is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to extend the exercise period of a total of 2,943,717 outstanding common share purchase warrants (the “Warrants”), all of which are held by arm’s length parties, for a period of one year from their current expiry dates – to March 23, 2024.
Mar 9, 2023
IFABRIC ANNOUNCES PROPOSED CHANGE IN YEAR END
IFABRIC CORP. (“iFabric” or the "Company") (TSX:IFA)(OTCQX:IFABF) is pleased to announce that it will be changing its fiscal year-end to December 31, from its current fiscal year-end of September 30. The notice for the year-end change required under National Instrument 51-102 has been filed under the Company’s profile at www.sedar.com.
Jan 31, 2023
IFABRIC CORP ANNOUNCES EPA REGISTRATION OF NEW TECHNOLOGY, bioACTIV AM.
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA, OTCQX: IFABF), today announced that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has received a United States Environmental Agency ("EPA") registration for its innovative new multifunctional technology, bioACTIV AM, which combines anti-microbial, anti-viral, deodorant and UV Protection into a single formulation.
Jul 20, 2022
iFABRIC CORP UPDATES ON CLINICAL TRIAL FOR TREATED MEDICAL SCRUBS
iFabric Corp. (“iFabric” or the “Company”) (TSX: IFA, OTCQX: IFABF), today provides an update on its clinical trial of medical garments (i.e. “scrubs”) treated with the Company’s ProTX2 antimicrobial and REPELTX water-repellent technologies.
Jul 4, 2022
iFabric Signs New Agreement With The North Face
iFabric Corp. hereinafter referred to as (“iFabric” or the “Company”) (TSX: IFA, OTCQX: IFABF), today announced that its wholly owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. (“IFTNA”), has signed a new license agreement with The North Face® (“TNF”), a division of VF Outdoor LLC. (“VF”). The agreement provides The North Face® with a license to use RepelTX ecoPEL in outdoor apparel, footwear and equipment manufactured and distributed by The North Face® (“TNF”).
Jun 1, 2022
IFABRIC ANNOUNCES LICENSE AGREEMENT WITH ROOTS CORPORATION
iFabric Corp. (TSX: IFA, OTCQX: IFABF) (“iFabric”) is pleased to announce the execution of a license agreement between Roots Corporation (“Roots”) and iFabric’s wholly-owned subsidiary, Intelligent Fabric Technologies (North America) Inc. (“IFTNA”). The license provides IFTNA with the right to use the Roots trademarks in connection with the manufacture and distribution of men’s, women’s and children’s swimwear, to retailers and distribution channels approved by Roots, including Roots stores.